Evidence map›Paper›PMID 37597815›Full record

ArticleNeurobiology of disease2023

Reactive astrocytes associated with prion disease impair the blood brain barrier.

Rajesh Kushwaha, Yue Li, Natallia Makarava, Narayan P Pandit, Kara Molesworth, Konstantin G Birukov, Ilia V Baskakov

Open access · goldAbstract read
In one paragraph

Article in Neurobiology of disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rajesh KushwahaCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, MD 21201, United States of America; Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201, United States of America.
Yue LiLung Biology Research Program and Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, MD 21201, United States of America.
Natallia MakaravaCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, MD 21201, United States of America; Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201, United States of America.
Narayan P PanditCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, MD 21201, United States of America; Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201, United States of America.
Kara MolesworthCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, MD 21201, United States of America; Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201, United States of America.
Konstantin G BirukovLung Biology Research Program and Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, MD 21201, United States of America.
Ilia V BaskakovCenter for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, MD 21201, United States of America; Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201, United States of America. Electronic address: Baskakov@som.umaryland.edu.
University of Maryland, Baltimore · US

Funding

Self-Propagating Mechanism of Prion DiseasesR01NS045585 · NINDS · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI Ilia V Baskakov · 2003 to 2026
$9.6M
Control of Lung Permeability by Oxidized PhospholipidsR01HL076259 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BIRUKOV, KONSTANTIN · 2004 to 2023
$6.8M
Role of reactive astrocytes in prion diseasesR01NS129502 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI Ilia V Baskakov · 2023 to 2026
$2.5M
Modulation of inflammation in aging lungR01HL146829 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BIRUKOV, KONSTANTIN · 2020 to 2023
$1.5M
NHLBI NIH HHS R01 HL076259NHLBI NIH HHS R01 HL146829NINDS NIH HHS R01 NS045585NINDS NIH HHS R01 NS129502
6 · The paper itself

Abstract

backgroundImpairment of the blood-brain barrier (BBB) is considered to be a common feature among neurodegenerative diseases, including Alzheimer's, Parkinson's and prion diseases. In prion disease, increased BBB permeability was reported 40 years ago, yet the mechanisms behind the loss of BBB integrity have never been explored. Recently, we showed that reactive astrocytes associated with prion diseases are neurotoxic. The current work examines the potential link between astrocyte reactivity and BBB breakdown.

resultsIn prion-infected mice, the loss of BBB integrity and aberrant localization of aquaporin 4 (AQP4), a sign of retraction of astrocytic endfeet from blood vessels, were noticeable prior to disease onset. Gaps in cell-to-cell junctions along blood vessels, together with downregulation of Occludin, Claudin-5 and VE-cadherin, which constitute tight and adherens junctions, suggested that loss of BBB integrity is linked with degeneration of vascular endothelial cells. In contrast to cells isolated from non-infected adult mice, endothelial cells originating from prion-infected mice displayed disease-associated changes, including lower levels of Occludin, Claudin-5 and VE-cadherin expression, impaired tight and adherens junctions, and reduced trans-endothelial electrical resistance (TEER). Endothelial cells isolated from non-infected mice, when co-cultured with reactive astrocytes isolated from prion-infected animals or treated with media conditioned by the reactive astrocytes, developed the disease-associated phenotype observed in the endothelial cells from prion-infected mice. Reactive astrocytes were found to produce high levels of secreted IL-6, and treatment of endothelial monolayers originating from non-infected animals with recombinant IL-6 alone reduced their TEER. Remarkably, treatment with extracellular vesicles produced by normal astrocytes partially reversed the disease phenotype of endothelial cells isolated from prion-infected animals.

conclusionsTo our knowledge, the current work is the first to illustrate early BBB breakdown in prion disease and to document that reactive astrocytes associated with prion disease are detrimental to BBB integrity. Moreover, our findings suggest that the harmful effects are linked to proinflammatory factors secreted by reactive astrocytes.

Indexed as

Prion DiseasesPrionsAnimalsAstrocytesBlood-Brain BarrierClaudin-5Endothelial CellsInterleukin-6MiceOccludinClaudin-5Interleukin-6OccludinPrionsBlood-brain barrierEndothelial cellsNeuroinflammationOccludin, Claudin-5 or VE-cadherinPrion diseasesPrionsReactive astrocytes

Identifiers

PMID37597815
PMCPMC10494928
OpenAlexW4385988850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.